Lavie Bio
在场
高管
查看带有其 10 名主要高管的组织结构图
Lavie Bio 搜索最多的简介
高管在Compugen变化
- David SilbermanDavid Silberman 将于20248月15作为 Chief Financial Officer 加入公司 (新闻发布的2024五月16号).
- Alberto Sessa, Chief Financial Officer, 将于 20248月15 退休 (新闻发布的2024五月16号).
创建提醒
跟踪 Lavie Bio 的高管变动
生物技术
Compugen 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Lavie Bio 的最新新闻稿
- Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - Lavie Bio
- Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Lavie Bio
- ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants - Lavie Bio
- Syngenta and Lavie Bio team up to speed up the R&D process for biopesticides
- Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat - Lavie Bio
- Newsroom - Lavie Bio
- Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing - Lavie Bio
- Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America - Lavie Bio
- Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide - Lavie Bio
- Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements - Lavie Bio
- View more press releases Close
通过电子邮件
